Sharp BSM

Partner Content

A quick guide to transferring a commercial drug product to a new fill-finish CDMO

Between 2012 and 2021, outsourcing propensity for FDA NDA injectables approvals averaged 40%, according to GlobalData’s Contract Injectable Packaging Trends…

Miranda McLaren

Partner Content

Overcoming common challenges in fill/finish for monoclonal antibodies (mAbs)

Partner Content

What’s involved in designing effective lyophilization cycles?

Partner Content

Cutting losses in drug manufacturing: A new era in fill-finish technology

Partner Content

Strategies and innovations for reducing drug product loss in sterile filling

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

A quick guide to transferring a commercial drug product to a new fill-finish CDMO

Overcoming common challenges in fill/finish for monoclonal antibodies (mAbs)

What’s involved in designing effective lyophilization cycles?

Cutting losses in drug manufacturing: A new era in fill-finish technology

Strategies and innovations for reducing drug product loss in sterile filling

Medical packaging companies in pharmaceutical contract manufacturing

Pharma packaging solutions, design and companies

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief